News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
109,173 Results
Type
Article (3302)
Company Profile (49)
Press Release (105822)
Multimedia
Podcasts (4)
Webinars (3)
Section
Business (33485)
Career Advice (203)
Deals (9911)
Drug Delivery (10)
Drug Development (10473)
Employer Resources (12)
FDA (1717)
Job Trends (2251)
News (55617)
Policy (3717)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
2026 Pharm Country Premier (1)
Academia (223)
Allergies (15)
Alliances (8934)
ALS (12)
Alzheimer's disease (179)
Antibody-drug conjugate (ADC) (21)
Approvals (1732)
Artificial intelligence (24)
Autoimmune disease (3)
Automation (3)
Bankruptcy (94)
Best Places to Work (1813)
BIOSECURE Act (2)
Biosimilars (18)
Biotechnology (35)
Bladder cancer (12)
Brain cancer (7)
Breast cancer (39)
Cancer (342)
Cardiovascular disease (12)
Career advice (172)
Career pathing (1)
CAR-T (22)
Cell therapy (71)
Cervical cancer (3)
Clinical research (8587)
Collaboration (148)
Compensation (76)
COVID-19 (260)
CRISPR (7)
C-suite (49)
Cystic fibrosis (12)
Data (315)
Denatured (3)
Depression (6)
Diabetes (29)
Diagnostics (1091)
Digital health (4)
Diversity, equity & inclusion (2)
Drug discovery (22)
Drug pricing (9)
Duchenne muscular dystrophy (15)
Earnings (11141)
Editorial (3)
Employer branding (2)
Employer resources (10)
Events (15735)
Executive appointments (186)
FDA (1882)
Featured Employer (7)
Frontotemporal dementia (1)
Funding (158)
Gene editing (17)
Generative AI (1)
Gene therapy (27)
GLP-1 (83)
Government (323)
Grass and pollen (3)
Guidances (4)
Healthcare (2639)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (19)
Indications (6)
Infectious disease (275)
Inflammatory bowel disease (26)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (19)
Interviews (29)
IPO (5562)
IRA (7)
Job creations (479)
Job search strategy (153)
Kidney cancer (4)
Labor market (4)
Layoffs (46)
Leadership (1)
Legal (1084)
Liver cancer (9)
Lung cancer (49)
Lymphoma (16)
Management (4)
Manufacturing (34)
MASH (10)
Medical device (2078)
Medtech (2078)
Mergers & acquisitions (4646)
Metabolic disorders (75)
Multiple sclerosis (14)
NASH (1)
Neurodegenerative disease (11)
Neuropsychiatric disorders (3)
Neuroscience (270)
NextGen: Class of 2025 (1207)
Non-profit (307)
Northern California (578)
Now hiring (4)
Obesity (33)
Opinion (18)
Ovarian cancer (16)
Pain (18)
Pancreatic cancer (19)
Parkinson's disease (23)
Partnered (5)
Patents (55)
Patient recruitment (15)
Peanut (6)
People (11452)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (3019)
Phase II (4079)
Phase III (2642)
Pipeline (213)
Policy (13)
Postmarket research (176)
Preclinical (1228)
Press Release (3)
Prostate cancer (10)
Psychedelics (3)
Radiopharmaceuticals (53)
Rare diseases (48)
Real estate (907)
Recruiting (6)
Regulatory (2586)
Reports (9)
Research institute (279)
Resumes & cover letters (23)
RSV (3)
Schizophrenia (20)
Series A (30)
Series B (11)
Service/supplier (2)
Sickle cell disease (9)
Southern California (613)
Special edition (1)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (924)
State (1)
Stomach cancer (2)
Supply chain (10)
The Weekly (1)
United States (4621)
Vaccines (51)
Venture capitalists (8)
Weight loss (14)
Women's health (1)
Worklife (1)
Date
Today (28)
Last 7 days (127)
Last 30 days (447)
Last 365 days (6234)
2025 (1842)
2024 (6798)
2023 (8035)
2022 (9934)
2021 (11250)
2020 (10468)
2019 (7103)
2018 (5461)
2017 (5502)
2016 (4660)
2015 (6121)
2014 (4310)
2013 (3565)
2012 (3909)
2011 (3572)
2010 (3175)
Location
Africa (62)
Alabama (3)
Arizona (36)
Arkansas (1)
Asia (5469)
Australia (755)
California (1466)
Canada (267)
China (71)
Colorado (42)
Connecticut (54)
Delaware (15)
Europe (8901)
Florida (178)
Georgia (28)
Idaho (10)
Illinois (68)
India (2)
Indiana (85)
Japan (16)
Kansas (28)
Kentucky (1)
Maine (35)
Maryland (119)
Massachusetts (735)
Michigan (70)
Minnesota (55)
Mississippi (2)
Missouri (14)
Montana (2)
Nebraska (4)
Nevada (28)
New Hampshire (9)
New Jersey (329)
New Mexico (2)
New York (331)
North Carolina (272)
Northern California (578)
Ohio (53)
Oklahoma (2)
Oregon (7)
Pennsylvania (229)
Rhode Island (4)
South America (100)
South Carolina (7)
Southern California (613)
Tennessee (24)
Texas (225)
Utah (45)
Virginia (30)
Washington D.C. (2)
Washington State (101)
West Virginia (1)
Wisconsin (16)
109,173 Results for "ait bioscience llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
April 3, 2025
·
4 min read
Press Releases
Kashiv BioSciences, LLC Obtains Marketing Authorization for Pegfilgrastim Injection from Health Canada
February 26, 2025
·
2 min read
Press Releases
Rancho BioSciences, LLC Awarded Great Place to Work(R) Certification for the Third Consecutive Year
December 12, 2024
·
2 min read
Stallergenes Greer Publishes in the Lancet Regional Health-Europe Landmark EfficAPSI Real-world Study Confirming Significant Benefit of Its Liquid Sublingual AIT on the Onset and Progression of Allergic Asthma
Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy, announced that results of its EfficAPSI real-world study evaluating the impact of Stallergenes Greer liquid sublingual AIT on asthma onset and evolution in patients with allergic rhinitis have been published in the Lancet Regional Health-Europe.
May 2, 2024
·
9 min read
Deals
Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC
Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC.
November 27, 2023
·
4 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Press Releases
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - April 25, 2025
April 28, 2025
·
3 min read
Press Releases
Innovative Lab Services LLC Acquires PL Consultants, LLC to Expand Scientific Capabilities and Service Offerings
January 15, 2025
·
2 min read
Press Releases
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
April 2, 2025
·
6 min read
Press Releases
H.C. Wainwright & Co., LLC Announces the Hiring of Elemer Piros and Brandon Folkes as Senior Research Analysts, and Expansion of Institutional Sales Team
April 22, 2025
·
2 min read
1 of 10,918
Next
